Potential Therapeutic Effects of Human Amniotic Epithelial Cells on Gynecological Disorders Leading to Infertility or Abortion Publisher Pubmed

Summary: Review highlights human amniotic epithelial cells' immunomodulatory potential for treating infertility & pregnancy complications. #StemCells #Immunomodulation

Rezayat F¹ ; Esmaeil N^{1, 2, 3} ; Rezaei A¹
Source: Stem Cell Reviews and Reports Published:2023

Abstract

Abstract: The induction of feto-maternal tolerance, fetal non-immunogenicity, and the regulation of mother’s immune system are essential variables in a successful pregnancy. Fetal membranes have been used as a source of stem cells and biological components in recent decades. Human amniotic epithelial cells (hAEC) have stem/progenitor characteristics like those found in the amniotic membrane. Based on their immunomodulatory capabilities, recent studies have focused on the experimental and therapeutic applications of hAECs in allograft transplantation, autoimmune disorders, and gynecological problems such as recurrent spontaneous abortion (RSA), recurrent implantation failure (RIF), and premature ovarian failure (POF). This review discusses some of the immunomodulatory features and therapeutic potential of hAECs in preventing infertility, miscarriage, and implantation failure by controlling the maternal immune system. Graphical Abstract: [Figure not available: see fulltext.] © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.